bioAffinity Technologies, Inc. (BIAFW) stock
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
bioAffinity Technologies r&d expenses
Research and development expenses are spending on new products and technology.
bioAffinity Technologies's R&D Expenses for the twelve months ending Jun 30, 2026 was $1.42M, up 5.4% year over year. For fiscal 2025 it was $1.38M, down 5.3% from the year before. The highest annual figure on record is $1.47M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.38M | -5.3% |
| FY2024 | Dec 31, 2024 | $1.46M | -0.5% |
| FY2023 | Dec 31, 2023 | $1.47M | +6.5% |
| FY2022 | Dec 31, 2022 | $1.38M | +36.8% |
| FY2021 | Dec 31, 2021 | $1.01M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $361.58K | +16.1% |
| Q1 FY2026 | Mar 31, 2026 | $349.71K | -4.8% |
| Q4 FY2025 | Dec 31, 2025 | $374.01K | -4.3% |
| Q3 FY2025 | Sep 30, 2025 | $330.59K | +20.4% |
| Q2 FY2025 | Jun 30, 2025 | $311.37K | -22.6% |
| Q1 FY2025 | Mar 31, 2025 | $367.39K | -6.7% |
| Q4 FY2024 | Dec 31, 2024 | $390.66K | -9.7% |
| Q3 FY2024 | Sep 30, 2024 | $274.50K | -16.9% |
| Q2 FY2024 | Jun 30, 2024 | $402.43K | +20.1% |
| Q1 FY2024 | Mar 31, 2024 | $393.64K | +6.5% |
| Q4 FY2023 | Dec 31, 2023 | $432.82K | +0.8% |
| Q3 FY2023 | Sep 30, 2023 | $330.38K | +3.3% |
| Q2 FY2023 | Jun 30, 2023 | $335.13K | +34.9% |
| Q1 FY2023 | Mar 31, 2023 | $369.62K | +32.1% |
| Q4 FY2022 | Dec 31, 2022 | $429.24K | +230.7% |
| Q3 FY2022 | Sep 30, 2022 | $319.74K | -3.3% |
| Q2 FY2022 | Jun 30, 2022 | $248.42K | – |
| Q1 FY2022 | Mar 31, 2022 | $279.85K | – |
| Q4 FY2021 | Dec 31, 2021 | $129.80K | – |
| Q3 FY2021 | Sep 30, 2021 | $330.77K | – |